AAOpt 2024: Takeaways from this year's conference

News
Video

ODs share what they learned at this year's Academy meeting and what they plan to take home to their practices.

Eye care providers far and wide came to lecture and learn about the latest innovations in eye care at this year's AAOpt meeting in Indianapolis, Indiana, from November 6-9. The key takeaways from this optometry conference include the exciting advancements in ocular surface treatments and technologies, as well as the ongoing research into the genetics and progression of keratoconus. Several speakers highlighted the wealth of new products and treatments in the pipeline, with Ian Ben Gaddie, OD, FAAO, noting that in a single course, they reviewed 6-7 promising new ocular surface products that will be available in the next 3 years. This speaks to the rapid pace of innovation in the field and the enthusiasm among clinicians about these advancements.

Clark Chang, OD, MSA, MSc, FAAO, discussed an excellent session on the genetics of keratoconus, a topic of great interest given the recent loss of access to a genetic test for the condition in the US market. The presenters have mapped over 200 genes related to keratoconus and are working to develop an improved polygenic risk score. Importantly, they also found that different genes may govern the progression versus the phenotypic expression of the disease, which could help clinicians better monitor and manage their keratoconus patients.

Bill R. Hammond also touched on the growing collaboration between academia and industry, noting that researchers are increasingly working with companies to translate their basic science findings into real-world products and treatments that can improve people's lives. This synergy between the academic and commercial worlds was seen as very positive. Finally, the increasing integration of nutrition and preventative care into optometric education and conferences was highlighted as an encouraging trend, helping to solidify the connection between eye health and overall wellness.

Overall, optometrists conveyed a sense of excitement and optimism about the future of eye care, driven by scientific advancements, cross-disciplinary collaboration, and a focus on holistic patient outcomes.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.